RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire16:05 ET

RxSight, Inc.'s (NASDAQ:RXST) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors

Simply Wall StDec 26, 2024 05:00 ET

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT NewswiresDec 20, 2024 15:57 ET

RxSight Down Over 13%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow JonesDec 20, 2024 15:35 ET

Stifel Downgrades RxSight(RXST.US) to Hold Rating, Cuts Target Price to $40

Moomoo NewsDec 20, 2024 13:31 ET · Ratings

Hold Rating Issued Amidst Rising Competition and Market Uncertainty for RxSight

TipRanksDec 20, 2024 12:58 ET · Ratings